The effects of Telmisartan, an angiotensinII type 1 receptor blocker, in reducing AAA growth in patients with abdominal aortic aneurysm.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Telmisartan (Primary)
- Indications Aneurysm
- Focus Therapeutic Use
- Acronyms TEDY
- 07 Jun 2017 Biomarkers information updated
- 03 Apr 2017 Planned End Date changed from 1 Aug 2016 to 1 Aug 2017.
- 03 Apr 2017 Planned primary completion date changed from 1 Apr 2016 to 1 Apr 2017.